lisofylline has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldari, CT; Capitani, N; Cattaneo, F; D'Elios, MM; Frezzato, F; Patrussi, L; Semenzato, G; Trentin, L | 1 |
1 other study(ies) available for lisofylline and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells.
Topics: Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Interleukin-12; Leukemia, Lymphocytic, Chronic, B-Cell; Pentoxifylline; Phosphorylation; Promoter Regions, Genetic; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; STAT4 Transcription Factor; Tumor Microenvironment | 2016 |